Skip to main content
Home > Week in Review > Other News

Chronological Index of : Other News

 Current Issue
  • Cortexyme Inc, EpiBone, G-Tech gastrointestinal, musculoskeletal, neurology news

    Cortexyme Inc., San Francisco, Calif. EpiBone Inc., New York, N.Y. G-Tech, Palo Alto, Calif. Business: Gastrointestinal, Musculoskeletal, Neurology The companies each received a $350,000 award from the Thiel Foundations…

    Published on 6/23/2014
  • Gilead Sciences Inc infectious news

    Gilead Sciences Inc. (NASDAQ:GILD), Foster City, Calif. Business: Infectious Reps. Henry Waxman (D-Calif.) and Diana DeGette (D-Colo.) wrote to House Energy and Commerce Committee majority leadership to request a …

    Published on 6/23/2014
  • Maxygen Inc other news

    Maxygen Inc., San Mateo, Calif. Business: Other Maxygens board approved a second and final liquidating distribution of $0.09 per share, to be paid on or about June 30. Shareholders received an initial payout of $69.5 …

    Published on 6/23/2014
  • Merck & Co. endocrine/metabolic news

    Merck & Co. (NYSE:MRK), Whitehouse Station, N.J. Business: Endocrine/Metabolic Merck launched a global prospective registry to evaluate the outcomes of about 20,000 Type II diabetics in real-word settings. The registry …

    Published on 6/23/2014
  • Myriad Genetics Inc, Pathway Genomics diagnostic news

    Myriad Genetics Inc. (NASDAQ:MYGN), Salt Lake City, Utah Pathway Genomics Corp., San Diego, Calif. Business: Diagnostic Myriad filed suit against Pathway in the U.S. District Court for the District of Utah, Central …

    Published on 6/23/2014
  • Novartis A infectious news

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Infectious Novartis said FDA licensed the pharmas manufacturing facility in Holly Springs, N.C., to produce cell-culture influenza vaccines. Novartis said …

    Published on 6/23/2014
  • Novartis A pharmaceuticals news

    Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Business: Pharmaceuticals Novartis said that an ongoing, internal review of adverse event reporting practices in the pharmas Japanese Novartis Pharma K.K. (NPKK) …

    Published on 6/23/2014
  • Teva Pharmaceutical Industries Ltd, Bristol-Myers infectious news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel Bristol-Myers Squibb Co. (NYSE:BMY), New York, N.Y. Business: Infectious The U.S. Court of Appeals for the Federal Circuit upheld a February 2013 …

    Published on 6/23/2014
  • TransCelerate BioPharma Inc other news

    TransCelerate BioPharma Inc., Philadelphia, Pa. Business: Other TransCelerate launched an initiative to develop a position paper on methods for redacting privacy information found in clinical study reports. The …

    Published on 6/23/2014
  • Alere diagnostic news

    Alere Inc. (NYSE:ALR), Waltham, Mass. Business: Diagnostic Alere announced as part of the ongoing review of its corporate governance policies, the diagnostic company has decided to separate the roles of chairman and CEO…

    Published on 5/12/2014
  • American Society of Clinical Oncology (ASCO) cancer news

    American Society of Clinical Oncology (ASCO), Alexandria, Va. Business: Cancer ASCO is seeking stakeholder input on a proposed bundled payment system for oncology practices that the group said would tie payments to …

    Published on 5/12/2014
  • Biota Pharmaceuticals, U.S. Department of Health and Human Services infectious news

    Biota Pharmaceuticals Inc. (NASDAQ:BOTA), Alpharetta, Ga. U.S. Department of Health and Human Services, Washington, D.C. Business: Infectious Biota said HHS's Office of the Assistant Secretary for Preparedness and …

    Published on 5/12/2014
  • Cellular Dynamics, Memorial Sloan Kettering neurology news

    Cellular Dynamics International Inc. (NASDAQ:ICEL), Madison, Wis. Memorial Sloan Kettering Cancer Center, New York, N.Y. Business: Neurology Cellular Dynamics launched iCell DopaNeurons worldwide for use as an in vitro …

    Published on 5/12/2014
  • Cytos inflammation, infectious news

    Cytos Biotechnology AG (SIX:CYTN), Schlieren, Switzerland Business: Inflammation, Infectious Cytos said it is winding down key operational activities, particularly related to development and manufacturing of CYT003, and…

    Published on 5/12/2014
  • Enzon infectious news

    Enzon Pharmaceuticals Inc. (NASDAQ:ENZN), Bridgewater, N.J. Business: Infectious Enzon's board adopted a stockholder rights plan to reduce the likelihood of an "unintended" ownership change. Under the plan, shareholders…

    Published on 5/12/2014
  • J&J, WHO infectious news

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. World Health Organization, Geneva, Switzerland Business: Infectious Johnson & Johnson's Janssen Pharmaceutica N.V. subsidiary partnered with the Stop TB Partnership's …

    Published on 5/12/2014
  • Teva, FDA neurology, generics news

    Teva Pharmaceutical Industries Ltd. (NYSE:TEVA), Petah Tikva, Israel U.S. Food and Drug Administration (FDA), Silver Spring, Md. Business: Neurology, Generics Teva filed a suit against FDA in the U.S. District Court for…

    Published on 5/12/2014
  • TNI BioTech cancer, inflammation, infectious news

    TNI BioTech Inc. (OTCQB:TNIB), Bethesda, Md. Business: Cancer, Inflammation, Infectious TNI will spin out its wholly owned subsidiary Cytocom Inc. to operate TNI's drug development business. The newco will initially …

    Published on 5/12/2014
  • U.S. Department of Health and Human Services, U.S. Department of Labor, U.S. Department of the Treasury neurology news

    U.S. Department of Health and Human Services, Washington, D.C. U.S. Department of Labor, Washington, D.C. U.S. Department of the Treasury, Washington, D.C. Business: Neurology A Q&A document prepared jointly by HHS, the…

    Published on 5/12/2014
  • Actavis, Apotex, Dr. Reddy's, Mylan, Orchid Chemicals & Pharmaceuticals, Roche musculoskeletal news

    Actavis plc (NYSE:ACT), Dublin, Ireland Apotex Inc., Toronto, Ontario Dr. Reddy's Laboratories Ltd. (NYSE:RDY), Hyderabad, India Mylan Inc. (NASDAQ:MYL), Canonsburg, Pa. Orchid Chemicals & Pharmaceuticals Ltd. (BSE:…

    Published on 4/21/2014
  • Astellas, U.S. Department of Justice infectious news

    Astellas Pharma Inc. (Tokyo:4503), Tokyo, Japan U.S. Department of Justice, Washington, D.C. Business: Infectious Astellas will pay $7.3 million to the U.S. Department of Justice to resolve civil claims alleging off-…

    Published on 4/21/2014
  • Delaware State Senate biosimilars news

    Delaware State Senate, Dover, Del. Business: Biosimilars The Delaware State Senate passed a bill that authorizes pharmacists to substitute an FDA-approved interchangeable biosimilar for a prescribed biological product. …

    Published on 4/21/2014
  • Federal Joint Committee (G-BA) pharmaceuticals news

    Federal Joint Committee (G-BA), Berlin, Germany Business: Pharmaceuticals G-BA formally ended assessments of drugs that were launched before January 2011, when drug pricing law AMNOG came into effect. The move comes …

    Published on 4/21/2014
  • Genentech, Novartis, Roche ophthalmic news

    Genentech Inc., South San Francisco, Calif. Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Roche (SIX:ROG; OTCQX:RHHBY), Basel, Switzerland Business: Ophthalmic Roche and Novartis confirmed French authorities …

    Published on 4/21/2014
  • J&J, Scripps Research Institute other news

    Johnson & Johnson (NYSE:JNJ), New Brunswick, N.J. The Scripps Research Institute, La Jolla, Calif. Business: Other The institute launched Scripps Advance to identify and invest in early stage biomedical research …

    Published on 4/21/2014

< Previous   1  2  3  4  5  6  Next >
Subscribe Now
Free Trial

About BioCentury

Decision-shaping business intelligence for the global biotech and pharma industry since 1993